ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
van der Werf MJ, de Vlas SJ, 2001. Morbidity and Infection with Schistosomes or Soil-Transmitted Helminths. Rotterdam: Erasmus University, 1–103.
-
2
Chen MG, Mott KE, 1989. Progress in assessment of morbidity due to Schistosoma haematobium infection. Trop Dis Bull 86 :R1–R36.
-
3
Smith JH, Christie JD, 1986. The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 17 :333–345.
-
4
WHO, 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Geneva: World Health Organization.
-
5
King CH, 2001. Disease in schistosomiasis haematobia. Mahmoud AAF, ed. Schistosomiasis. London: Imperial College Press, 265–296.
-
6
King CH, Muchiri E, Ouma JH, Koech D, 1991. Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. Am J Trop Med Hyg 45 :498–508.
-
7
Hatz CF, Vennervald BJ, Nkulila T, Vounatsou P, Kombe Y, Mayombana C, Mshinda H, Tanner M, 1998. Evolution of Schistosoma haematobium–related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Am J Trop Med Hyg 59 :775–781.
-
8
King CH, Muchiri EM, Ouma JH, 2000. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerg Infect Dis 6 :585–594.
-
9
Gryseels B, 1989. The relevance of schistosomiasis for public health. Trop Med Parasitol 40 :134–142.
-
10
Tanner M, 1989. Evaluation of public health impact of schistosomiasis. Trop Med Parasitol 40 :143–148.
-
11
Muchiri EM, Ouma JH, King CH, 1996. Dynamics and control of Schistosoma haematobium transmission in Kenya: an overview of the Msambweni Project. Am J Trop Med Hyg 55 (Suppl):127–134.
-
12
Peters PAS, Kazura JW, 1987. Update on diagnostic methods for schistosomiasis. Mahmoud AAF, ed. Bailliere’s Clinical Tropical Medicine and Communicable Diseases, Schistosomiasis. London: Bailliere Tindall, 419–433.
-
13
Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM, 2000. Ultrasound in Schistosomiasis: A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-Related Morbidity. Geneva: World Health Organization.
-
14
Kleinbaum DG, Kupper LL, Morgenstern H, 1982. Epidemiologic Research: Principles and Quantitative Methods. New York: John Wiley & Sons.
-
15
Breslow NE, Day NE, 1980. Statistical Methods of Cancer Research. Volume 1. The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer.
-
16
King CH, 2001. Epidemiology of schistosomiasis: determinants of transmission of infection. Mahmoud AAF, ed. Schistosomiasis. London: Imperial College Press, 115–132.
-
17
Allison PD, 1999. Logistic Regression Using the SAS System: Theory and Application. Cary NC: SAS Institute Inc.
-
18
Clennon JA, King CH, Muchiri EM, Kariuki HC, Ouma JH, Mungai P, Kitron U, 2004. Spatial patterns of urinary schistosomiasis infection in a highly-endemic area of coastal Kenya. Am J Trop Med Hyg 70 :443–448.
-
19
Abdel-Wahab MF, Esmat G, Ramzy I, Narooz S, Medhat E, Ibrahim M, El-Boraey Y, Strickland GT, 2000. The epidemiology of schistosomiasis in Egypt: Fayoum Governorate. Am J Trop Med Hyg 62 :55–64.
-
20
Warren KS, Mahmoud AAF, 1976. Targeted mass treatment: a new approach to the control of schistosomiasis. Trans Assoc Am Physicians 89 :195–204.
-
21
Wilkins HA, Goll P, Marshall TF, Moore P, 1979. The significance of proteinuria and haematuria in Schistosoma haematobium infection. Trans R Soc Trop Med Hyg 73 :74–80.
-
22
Pugh RN, Bell DR, Gilles HM, 1980. Malumfashi Endemic Diseases Research Project, XV. The potential medical importance of bilharzia in northern Nigeria: a suggested rapid, cheap and effective solution for control of Schistosoma haematobium infection. Ann Trop Med Parasitol 74 :597–613.
-
23
Stolley PD, Strom BL, 1986. Sample size calculation for clinical pharmacology studies. Clin Pharmacol Ther :489–90.
-
24
Subramanian AK, Mungai P, Ouma JH, Magak P, King CH, Mahmoud AA, King CL, 1999. Long-term suppression of adult bladder morbidity and severe hydronephrosis following selective population chemotherapy for Schistosoma haematobium.Am J Trop Med Hyg 61 :476–481.
-
25
WHO, 2002. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of a WHO expert committee. World Health Organ Tech Rep Ser 912 :2–5.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 973 | 916 | 152 |
| Full Text Views | 216 | 12 | 0 |
| PDF Downloads | 54 | 12 | 2 |
LATE BENEFITS 10–18 YEARS AFTER DRUG THERAPY FOR INFECTION WITH SCHISTOSOMA HAEMATOBIUM IN KWALE DISTRICT, COAST PROVINCE, KENYA
JOHN H. OUMA
JOHN H. OUMA
Biomedical Science and Technology Programme, Maseno University, Maseno, Kenya; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio; Division of Vector Borne Diseases, Ministry of Health, Nairobi, Kenya; Kenya Medical Research Institute, Nairobi, Kenya; Nairobi X-Ray Services and Department of Radiology, Kenyatta National Hospital, Nairobi, Kenya
Search for other papers by JOHN H. OUMA in
Current site
Google Scholar
PubMed
Search for other papers by JOHN H. OUMA in
Current site
Google Scholar
PubMed
CHARLES H. KING
CHARLES H. KING
Biomedical Science and Technology Programme, Maseno University, Maseno, Kenya; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio; Division of Vector Borne Diseases, Ministry of Health, Nairobi, Kenya; Kenya Medical Research Institute, Nairobi, Kenya; Nairobi X-Ray Services and Department of Radiology, Kenyatta National Hospital, Nairobi, Kenya
Search for other papers by CHARLES H. KING in
Current site
Google Scholar
PubMed
Search for other papers by CHARLES H. KING in
Current site
Google Scholar
PubMed
ERIC M. MUCHIRI
ERIC M. MUCHIRI
Biomedical Science and Technology Programme, Maseno University, Maseno, Kenya; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio; Division of Vector Borne Diseases, Ministry of Health, Nairobi, Kenya; Kenya Medical Research Institute, Nairobi, Kenya; Nairobi X-Ray Services and Department of Radiology, Kenyatta National Hospital, Nairobi, Kenya
Search for other papers by ERIC M. MUCHIRI in
Current site
Google Scholar
PubMed
Search for other papers by ERIC M. MUCHIRI in
Current site
Google Scholar
PubMed
PETER MUNGAI
PETER MUNGAI
Biomedical Science and Technology Programme, Maseno University, Maseno, Kenya; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio; Division of Vector Borne Diseases, Ministry of Health, Nairobi, Kenya; Kenya Medical Research Institute, Nairobi, Kenya; Nairobi X-Ray Services and Department of Radiology, Kenyatta National Hospital, Nairobi, Kenya
Search for other papers by PETER MUNGAI in
Current site
Google Scholar
PubMed
Search for other papers by PETER MUNGAI in
Current site
Google Scholar
PubMed
DAVY K. KOECH
DAVY K. KOECH
Biomedical Science and Technology Programme, Maseno University, Maseno, Kenya; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio; Division of Vector Borne Diseases, Ministry of Health, Nairobi, Kenya; Kenya Medical Research Institute, Nairobi, Kenya; Nairobi X-Ray Services and Department of Radiology, Kenyatta National Hospital, Nairobi, Kenya
Search for other papers by DAVY K. KOECH in
Current site
Google Scholar
PubMed
Search for other papers by DAVY K. KOECH in
Current site
Google Scholar
PubMed
EDMUND IRERI
EDMUND IRERI
Biomedical Science and Technology Programme, Maseno University, Maseno, Kenya; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio; Division of Vector Borne Diseases, Ministry of Health, Nairobi, Kenya; Kenya Medical Research Institute, Nairobi, Kenya; Nairobi X-Ray Services and Department of Radiology, Kenyatta National Hospital, Nairobi, Kenya
Search for other papers by EDMUND IRERI in
Current site
Google Scholar
PubMed
Search for other papers by EDMUND IRERI in
Current site
Google Scholar
PubMed
PHILIP MAGAK
PHILIP MAGAK
Biomedical Science and Technology Programme, Maseno University, Maseno, Kenya; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio; Division of Vector Borne Diseases, Ministry of Health, Nairobi, Kenya; Kenya Medical Research Institute, Nairobi, Kenya; Nairobi X-Ray Services and Department of Radiology, Kenyatta National Hospital, Nairobi, Kenya
Search for other papers by PHILIP MAGAK in
Current site
Google Scholar
PubMed
Search for other papers by PHILIP MAGAK in
Current site
Google Scholar
PubMed
HILDA KADZO
HILDA KADZO
Biomedical Science and Technology Programme, Maseno University, Maseno, Kenya; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio; Division of Vector Borne Diseases, Ministry of Health, Nairobi, Kenya; Kenya Medical Research Institute, Nairobi, Kenya; Nairobi X-Ray Services and Department of Radiology, Kenyatta National Hospital, Nairobi, Kenya
Search for other papers by HILDA KADZO in
Current site
Google Scholar
PubMed
Search for other papers by HILDA KADZO in
Current site
Google Scholar
PubMed
Late benefits of remote antischistosomal therapy were estimated among long-term residents of an area with high transmission of Schistosoma haematobium (Msambweni, Kenya) by comparing infection and disease prevalence in two local adult cohorts. We compared 132 formerly treated adults (given treatment in childhood or adolescence ≥ 10 years previously) compared with 132 age- and sex-matched adults from the same villages who had not received prior treatment. The prevalence of current infection, hematuria, and ultrasound bladder abnormalities were significantly lower among the previously treated group, who were found to be free of severe bladder disease. Nevertheless, heavy infection was equally prevalent (2–3%) in both study groups, and present rates of hydronephrosis were not significantly different. Therapy given in childhood or adolescence appears to improve risk for some but not all manifestations of S. haematobium infection in later adult life. Future prospective studies of continued treatment into adulthood will better define means to obtain optimal, community-based control of S. haematobium-related disease in high-risk locations.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
van der Werf MJ, de Vlas SJ, 2001. Morbidity and Infection with Schistosomes or Soil-Transmitted Helminths. Rotterdam: Erasmus University, 1–103.
-
2
Chen MG, Mott KE, 1989. Progress in assessment of morbidity due to Schistosoma haematobium infection. Trop Dis Bull 86 :R1–R36.
-
3
Smith JH, Christie JD, 1986. The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 17 :333–345.
-
4
WHO, 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Geneva: World Health Organization.
-
5
King CH, 2001. Disease in schistosomiasis haematobia. Mahmoud AAF, ed. Schistosomiasis. London: Imperial College Press, 265–296.
-
6
King CH, Muchiri E, Ouma JH, Koech D, 1991. Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. Am J Trop Med Hyg 45 :498–508.
-
7
Hatz CF, Vennervald BJ, Nkulila T, Vounatsou P, Kombe Y, Mayombana C, Mshinda H, Tanner M, 1998. Evolution of Schistosoma haematobium–related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Am J Trop Med Hyg 59 :775–781.
-
8
King CH, Muchiri EM, Ouma JH, 2000. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerg Infect Dis 6 :585–594.
-
9
Gryseels B, 1989. The relevance of schistosomiasis for public health. Trop Med Parasitol 40 :134–142.
-
10
Tanner M, 1989. Evaluation of public health impact of schistosomiasis. Trop Med Parasitol 40 :143–148.
-
11
Muchiri EM, Ouma JH, King CH, 1996. Dynamics and control of Schistosoma haematobium transmission in Kenya: an overview of the Msambweni Project. Am J Trop Med Hyg 55 (Suppl):127–134.
-
12
Peters PAS, Kazura JW, 1987. Update on diagnostic methods for schistosomiasis. Mahmoud AAF, ed. Bailliere’s Clinical Tropical Medicine and Communicable Diseases, Schistosomiasis. London: Bailliere Tindall, 419–433.
-
13
Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM, 2000. Ultrasound in Schistosomiasis: A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-Related Morbidity. Geneva: World Health Organization.
-
14
Kleinbaum DG, Kupper LL, Morgenstern H, 1982. Epidemiologic Research: Principles and Quantitative Methods. New York: John Wiley & Sons.
-
15
Breslow NE, Day NE, 1980. Statistical Methods of Cancer Research. Volume 1. The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer.
-
16
King CH, 2001. Epidemiology of schistosomiasis: determinants of transmission of infection. Mahmoud AAF, ed. Schistosomiasis. London: Imperial College Press, 115–132.
-
17
Allison PD, 1999. Logistic Regression Using the SAS System: Theory and Application. Cary NC: SAS Institute Inc.
-
18
Clennon JA, King CH, Muchiri EM, Kariuki HC, Ouma JH, Mungai P, Kitron U, 2004. Spatial patterns of urinary schistosomiasis infection in a highly-endemic area of coastal Kenya. Am J Trop Med Hyg 70 :443–448.
-
19
Abdel-Wahab MF, Esmat G, Ramzy I, Narooz S, Medhat E, Ibrahim M, El-Boraey Y, Strickland GT, 2000. The epidemiology of schistosomiasis in Egypt: Fayoum Governorate. Am J Trop Med Hyg 62 :55–64.
-
20
Warren KS, Mahmoud AAF, 1976. Targeted mass treatment: a new approach to the control of schistosomiasis. Trans Assoc Am Physicians 89 :195–204.
-
21
Wilkins HA, Goll P, Marshall TF, Moore P, 1979. The significance of proteinuria and haematuria in Schistosoma haematobium infection. Trans R Soc Trop Med Hyg 73 :74–80.
-
22
Pugh RN, Bell DR, Gilles HM, 1980. Malumfashi Endemic Diseases Research Project, XV. The potential medical importance of bilharzia in northern Nigeria: a suggested rapid, cheap and effective solution for control of Schistosoma haematobium infection. Ann Trop Med Parasitol 74 :597–613.
-
23
Stolley PD, Strom BL, 1986. Sample size calculation for clinical pharmacology studies. Clin Pharmacol Ther :489–90.
-
24
Subramanian AK, Mungai P, Ouma JH, Magak P, King CH, Mahmoud AA, King CL, 1999. Long-term suppression of adult bladder morbidity and severe hydronephrosis following selective population chemotherapy for Schistosoma haematobium.Am J Trop Med Hyg 61 :476–481.
-
25
WHO, 2002. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of a WHO expert committee. World Health Organ Tech Rep Ser 912 :2–5.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 973 | 916 | 152 |
| Full Text Views | 216 | 12 | 0 |
| PDF Downloads | 54 | 12 | 2 |